April 29, 2025- When medtech earnings calls kicked off two weeks ago, a large question loomed over the industry about how the White House’s new tariff policies might affect businesses, according to MedTech Dive. Reciprocal tariffs were unveiled alongside an across-the-board levy of 10% on dozens of nations and territories in early April, according to CBS News. The answer from multiple companies has been that it would cost them hundreds of millions of dollars, according to MedTech Dive, with Boston Scientific saying that tariffs could cost the company $200 million; and Abbott said the levies would cost it a “few hundred million dollars.”